1. Home
  2. SRRK vs NPO Comparison

SRRK vs NPO Comparison

Compare SRRK & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • NPO
  • Stock Information
  • Founded
  • SRRK 2012
  • NPO 2002
  • Country
  • SRRK United States
  • NPO United States
  • Employees
  • SRRK N/A
  • NPO N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • NPO Metal Fabrications
  • Sector
  • SRRK Health Care
  • NPO Industrials
  • Exchange
  • SRRK Nasdaq
  • NPO Nasdaq
  • Market Cap
  • SRRK 4.2B
  • NPO 3.7B
  • IPO Year
  • SRRK 2018
  • NPO N/A
  • Fundamental
  • Price
  • SRRK $43.12
  • NPO $173.39
  • Analyst Decision
  • SRRK Strong Buy
  • NPO Buy
  • Analyst Count
  • SRRK 7
  • NPO 2
  • Target Price
  • SRRK $40.43
  • NPO $217.50
  • AVG Volume (30 Days)
  • SRRK 1.1M
  • NPO 96.5K
  • Earning Date
  • SRRK 11-12-2024
  • NPO 02-18-2025
  • Dividend Yield
  • SRRK N/A
  • NPO 0.69%
  • EPS Growth
  • SRRK N/A
  • NPO N/A
  • EPS
  • SRRK N/A
  • NPO 2.56
  • Revenue
  • SRRK N/A
  • NPO $1,039,400,000.00
  • Revenue This Year
  • SRRK N/A
  • NPO N/A
  • Revenue Next Year
  • SRRK N/A
  • NPO $3.43
  • P/E Ratio
  • SRRK N/A
  • NPO $67.62
  • Revenue Growth
  • SRRK N/A
  • NPO N/A
  • 52 Week Low
  • SRRK $6.76
  • NPO $136.68
  • 52 Week High
  • SRRK $46.19
  • NPO $197.94
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 57.37
  • NPO 51.27
  • Support Level
  • SRRK $38.72
  • NPO $166.97
  • Resistance Level
  • SRRK $45.15
  • NPO $173.53
  • Average True Range (ATR)
  • SRRK 2.33
  • NPO 3.84
  • MACD
  • SRRK -0.32
  • NPO 0.21
  • Stochastic Oscillator
  • SRRK 73.28
  • NPO 85.80

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which manufactures and markets sealing products, wheel-end components & systems, and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

Share on Social Networks: